Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SVF and PRP for Androgenetic Alopecia
NCT02865421Phase 2Completed
- Sponsor
- King Edward Medical University
- Start
- Jun 2017
- Primary completion
- Aug 2017
- Modality
- Stem Cell Therapies, Adoptive Cell Transfer
- Countries
- 1
01
Overview
Phase 2, open-label trial of autologous adipose stromal vascular fraction and autologous platelet-rich plasma in androgenetic alopecia (AGA), sponsored by King Edward Medical University. Primary endpoint: Hair pull test at 6 months. Started Jun 2017; status: completed.
02
Drugs
autologous adipose stromal vascular fractionautologous platelet-rich plasma
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT02865421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02865421.